The panelist discusses how systemic atopic dermatitis (AD) treatment involves biologics and Janus kinase inhibitors for moderate to severe cases, targeting inflammation and itch with individualized approach based on patient factors, offering significant symptom improvement and skin barrier restoration.
The panelist discusses how atopic dermatitis is a complex chronic skin condition causing significant physical and psychological burden, challenging patients and clinicians through multifaceted management requiring personalized, holistic approaches.
Lio emphasizes that patient comfort and understanding are essential for successful treatment outcomes.
Many patients, especially parents of pediatric patients, exhibit steroid phobia, impacting treatment adherence.
Swanson shared strategies for treating rural dermatology patients at MOPD 2025, emphasizing effective initial care, the role of telehealth, and practical treatments.
Corey Hartman, MD, FAAD, discusses how incorporating proper pre- and posttreatment protocols along with topical agents maximizes patient comfort and enhances treatment outcomes in laser therapy for pigmentary conditions.
A panelist discusses how using conservative laser settings, proper skin cooling, and careful patient selection is crucial when treating melasma and darker skin types to minimize post-inflammatory hyperpigmentation risks.
Corey Hartman, MD, FAAD, discusses how combining multiple laser modalities with proper patient education and realistic expectations leads to optimal outcomes when treating hyperpigmentation and other pigmentary disorders.
Long-term safety data suggests that JAK inhibitors have a lower risk of cardiovascular and thromboembolic events than previously thought.
Medical and aesthetic dermatologists partner at SBS 2025 to bridge gaps between clinical care and cosmetic procedures.
Michael Gold, MD, explored microneedling innovations, pulse wave technology for pigmentation, and the aesthetic effects of GLP-1 receptor agonists, including "Ozempic face" and skin laxity.
Compliance with acne medications remains a challenge, but timely intervention can prevent severe skin damage.
Mona Shahriari, MD, FAAD advocates for improving diversity in clinical imagery and trials to enhance trust in patients with skin of color.
A holistic yet time-efficient approach can help dermatologists recognize early joint pain symptoms associated with psoriasis.
A balanced approach to dermatologic care involves using steroids for flare-ups and switching to non-steroidal options for maintenance.
Chilukuri said devices should be user-friendly even in solo practice settings to maximize efficiency and usability.
Michael Gold, MD, explored medical and procedural acne treatments and the emerging role of exosomes in regenerative dermatology.
Traditional descriptions often cater to lighter skin, necessitating updates to better serve diverse populations.
Advanced wound healing techniques, including exosomes and polynucleotides, can enhance post-procedure recovery and reduce pigmentation issues.
Nanette Silverberg, MD, discusses new treatments for pediatric vitiligo, including JAK inhibitors and surgical advancements.
Proper nutrition and nutraceuticals can help to manage skin conditions such as acne, eczema, and psoriasis.
A patient-centered approach ensures that hair loss treatments align with individual goals and medical history.
His presentation at South Beach Symposium will feature Zirwas’ insights on JAK inhibitors, eczema treatments, and emerging therapies.
“The most important tip as a physician, when you talk to the patient, sit down. Even if you sit down for 5 minutes, it's worth almost 5 hours,’ Leon Kircik, MD, said in his interview with Dermatology Times at SBS 2025.
Nada Elbuluk, MD, MSc, emphasizes that medical treatments remain first-line for vitiligo, but stable cases may benefit from surgical options.
Michael Gold, MD, shares why the South Beach Symposium remains a must-attend legacy event for dermatologists, blending education and innovation.
According to Silverberg, emotional resilience, social support, and purposeful activities help adolescents cope with acne-related stress.
Nanette Silverberg, MD, highlights new dermatology advancements and the significance of conferences like MOPD in shaping the future of treatment.
Dermatology Times staff will be onsite covering SBS 2025 with expert insights, interviews, and breaking news.
In an interview ahead of the main event, Ablon shared her excitement for SBS and listening in on presentations from industry leaders.
